These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32534728)

  • 21. Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey.
    Farnier M; Garnier P; Yau C; Dejager S; Verpilleux MP
    Int J Clin Pract; 2006 Oct; 60(10):1166-71. PubMed ID: 16942588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lipid distribution in the adult population of Catalonia].
    Plans P; Ruigómez J; Pardell H; Salleras L
    Rev Clin Esp; 1993 Jun; 193(1):35-42. PubMed ID: 8337460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines.
    Huang MC; Wang TN; Liu YL; Pa TH; Tu HP; Huang YC; Chang WT; Ko YC
    Circ J; 2006 Aug; 70(8):1030-6. PubMed ID: 16864937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertriglyceridemia accompanied by increased serum complement component 3 and proteinuria in non-nephrotic chronic kidney disease.
    Kohagura K; Kochi M; Miyagi T; Kinjyo T; Maehara Y; Kinjyo K; Nagahama K; Sakima A; Iseki K; Ohya Y
    Clin Exp Nephrol; 2014 Jun; 18(3):453-60. PubMed ID: 23757050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of moderate alcohol consumption on hypertriglyceridemia: a study in the fasting state.
    Pownall HJ; Ballantyne CM; Kimball KT; Simpson SL; Yeshurun D; Gotto AM
    Arch Intern Med; 1999 May; 159(9):981-7. PubMed ID: 10326940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study.
    Pallarés-Carratalá V; Ruiz-García A; Serrano-Cumplido A; Arranz-Martínez E; Divisón-Garrote JA; Moyá-Amengual A; Escobar-Cervantes C; Barrios V
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893564
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence, characteristics, and risk factors of elevated triglyceride levels in US children.
    Christian JB; Juneja MX; Meadowcroft AM; Borden S; Lowe KA
    Clin Pediatr (Phila); 2011 Dec; 50(12):1103-9. PubMed ID: 21816828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of prediabetes and association with cardiometabolic and renal factors. SIMETAP-PRED study.
    Arranz-Martínez E; Ruiz-García A; García Álvarez JC; Fernández Vicente T; Iturmendi Martínez N; Rivera-Teijido M;
    Clin Investig Arterioscler; 2022; 34(4):193-204. PubMed ID: 35120792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
    Rajmohan L; Deepa R; Mohan A; Mohan V
    Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic hypertension, diabetes mellitus, and dyslipidemia in relation to body mass index: evaluation of a Brazilian population.
    Cercato C; Mancini MC; Arguello AM; Passos VQ; Villares SM; Halpern A
    Rev Hosp Clin Fac Med Sao Paulo; 2004 Jun; 59(3):113-8. PubMed ID: 15286830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A reversal of decreasing trends in population cholesterol levels in Västerbotten County, Sweden.
    Ng N; Johnson O; Lindahl B; Norberg M
    Glob Health Action; 2012; 5():. PubMed ID: 22468143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseases.
    Ruiz-García A; Arranz-Martínez E; García-Álvarez JC; Morales-Cobos LE; García-Fernández ME; de la Peña-Antón N; Martín Calle MC; Díez Pérez MC; Montero Costa A; Palacios Martínez D; García Villasur MP; García Granado MAD; Lorenzo Borda MS; Cique Herráinz JA; Marañón Henrich N; Zarzuelo Martín N; Baltuille Aller MDC; Casaseca Calvo TF; Arribas Álvaro P; Macho Del Barrio AI; Moreno Fernández JC; Ribot Catalá C; Capitán Caldas M; Ciria de Pablo C; Sanz Velasco C; Simonaggio Stancampiano P; Vargas-Machuca Cabañero C; Sarriá Sánchez MT; Gómez Díaz E; Sanz Pozo B; Rodríguez de Mingo E; Cabello Igual MP; Rico Pérez MR; Migueláñez Valero A; Alcaraz Bethencourt A; Zafra Urango C; Chao Escuer P; Redondo de Pedro S; Escamilla Guijarro N; López Uriarte B; Rivera Teijido M;
    Clin Investig Arterioscler; 2018; 30(5):197-208. PubMed ID: 29980384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-based epidemiologic study on atherosclerotic cardiovascular risk factors.
    Park Y; Lee H; Koh CS; Min H
    Diabetes Res Clin Pract; 1996 Oct; 34 Suppl():S65-72. PubMed ID: 9015672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years.
    Rahman Al-Nuaim A
    Int J Cardiol; 1997 Dec; 62(3):227-35. PubMed ID: 9476683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of hypertriglyceridemia-induced acute pancreatitis in an international, multicenter, prospective cohort (APPRENTICE consortium).
    Pothoulakis I; Paragomi P; Archibugi L; Tuft M; Talukdar R; Kochhar R; Goenka MK; Gulla A; Singh VK; Gonzalez JA; Ferreira M; Barbu ST; Stevens T; Nawaz H; Gutierrez SC; Zarnescu NO; Easler J; Triantafyllou K; Pelaez-Luna M; Thakkar S; Ocampo C; de-Madaria E; Wu BU; Cote GA; Tang G; Papachristou GI; Capurso G
    Pancreatology; 2020 Apr; 20(3):325-330. PubMed ID: 32107193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical profile of patients with very high hypertriglyceridemia from the Registry of Hypertriglyceridemia of the Spanish Atherosclerosis Society].
    Pedragosa A; Merino J; Aranda JL; Galiana J; Godoy D; Panisello JM; Ascaso JF; Civeira F; Masana L; Pedro-Botet J;
    Clin Investig Arterioscler; 2013; 25(1):8-15. PubMed ID: 23522276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethnic and sex differences in hepatic lipid content and related cardiometabolic parameters in lean individuals.
    Petersen KF; Dufour S; Li F; Rothman DL; Shulman GI
    JCI Insight; 2022 Apr; 7(7):. PubMed ID: 35167495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996-99.
    Thiébaut R; Dequae-Merchadou L; Ekouevi DK; Mercié P; Malvy D; Neau D; Dabis F;
    HIV Med; 2001 Apr; 2(2):84-8. PubMed ID: 11737383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Significance of Serum Uric Acid Levels in Mexican Young Adults.
    Alegría-Díaz A; Valdez-Ortiz R; Murguía-Romero M; Jiménez-Flores R; Villalobos-Molina R; Mummidi S; Duggirala R; López-Alvarenga JC; Pérez-Navarro M
    Contrib Nephrol; 2018; 192():125-134. PubMed ID: 29393152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.